147 related articles for article (PubMed ID: 20424609)
1. Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer.
Salcido CD; Larochelle A; Taylor BJ; Dunbar CE; Varticovski L
Br J Cancer; 2010 May; 102(11):1636-44. PubMed ID: 20424609
[TBL] [Abstract][Full Text] [Related]
2. Irradiation Decreases the Neuroendocrine Biomarker Pro-Opiomelanocortin in Small Cell Lung Cancer Cells In Vitro and In Vivo.
Meredith SL; Bryant JL; Babur M; Riddell PW; Behrouzi R; Williams KJ; White A
PLoS One; 2016; 11(2):e0148404. PubMed ID: 26848743
[TBL] [Abstract][Full Text] [Related]
3. Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung Cancer.
Jahchan NS; Lim JS; Bola B; Morris K; Seitz G; Tran KQ; Xu L; Trapani F; Morrow CJ; Cristea S; Coles GL; Yang D; Vaka D; Kareta MS; George J; Mazur PK; Nguyen T; Anderson WC; Dylla SJ; Blackhall F; Peifer M; Dive C; Sage J
Cell Rep; 2016 Jul; 16(3):644-56. PubMed ID: 27373157
[TBL] [Abstract][Full Text] [Related]
4. A distinct "side population" of cells with high drug efflux capacity in human tumor cells.
Hirschmann-Jax C; Foster AE; Wulf GG; Nuchtern JG; Jax TW; Gobel U; Goodell MA; Brenner MK
Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14228-33. PubMed ID: 15381773
[TBL] [Abstract][Full Text] [Related]
5. Applied models and molecular characteristics of small cell lung cancer.
Fűr GM; Nemes K; Magó É; Benő AÁ; Topolcsányi P; Moldvay J; Pongor LS
Pathol Oncol Res; 2024; 30():1611743. PubMed ID: 38711976
[TBL] [Abstract][Full Text] [Related]
6. [Side population cells and lung cancer stem cells].
Pan Z; Zhou Q
Zhongguo Fei Ai Za Zhi; 2012 Mar; 15(3):187-90. PubMed ID: 22429584
[TBL] [Abstract][Full Text] [Related]
7. Endometrial cancer side-population cells show prominent migration and have a potential to differentiate into the mesenchymal cell lineage.
Kato K; Takao T; Kuboyama A; Tanaka Y; Ohgami T; Yamaguchi S; Adachi S; Yoneda T; Ueoka Y; Kato K; Hayashi S; Asanoma K; Wake N
Am J Pathol; 2010 Jan; 176(1):381-92. PubMed ID: 20008133
[TBL] [Abstract][Full Text] [Related]
8. CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist.
Sarvi S; Mackinnon AC; Avlonitis N; Bradley M; Rintoul RC; Rassl DM; Wang W; Forbes SJ; Gregory CD; Sethi T
Cancer Res; 2014 Mar; 74(5):1554-65. PubMed ID: 24436149
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines.
Wang P; Gao Q; Suo Z; Munthe E; Solberg S; Ma L; Wang M; Westerdaal NA; Kvalheim G; Gaudernack G
PLoS One; 2013; 8(3):e57020. PubMed ID: 23469181
[TBL] [Abstract][Full Text] [Related]
10. Cell of origin of lung cancer.
Sutherland KD; Berns A
Mol Oncol; 2010 Oct; 4(5):397-403. PubMed ID: 20594926
[TBL] [Abstract][Full Text] [Related]
11. Targets in small cell lung cancer.
Teicher BA
Biochem Pharmacol; 2014 Jan; 87(2):211-9. PubMed ID: 24091017
[TBL] [Abstract][Full Text] [Related]
12. The side population in human lung cancer cell line NCI-H460 is enriched in stem-like cancer cells.
Shi Y; Fu X; Hua Y; Han Y; Lu Y; Wang J
PLoS One; 2012; 7(3):e33358. PubMed ID: 22428030
[TBL] [Abstract][Full Text] [Related]
13. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.
Leung EL; Fiscus RR; Tung JW; Tin VP; Cheng LC; Sihoe AD; Fink LM; Ma Y; Wong MP
PLoS One; 2010 Nov; 5(11):e14062. PubMed ID: 21124918
[TBL] [Abstract][Full Text] [Related]
14. The role of human aldehyde dehydrogenase in normal and cancer stem cells.
Ma I; Allan AL
Stem Cell Rev Rep; 2011 Jun; 7(2):292-306. PubMed ID: 21103958
[TBL] [Abstract][Full Text] [Related]
15. Extracellular vesicles in non-small cell lung cancer stemness and clinical applications.
Pandya P; Al-Qasrawi DS; Klinge S; Justilien V
Front Immunol; 2024; 15():1369356. PubMed ID: 38765006
[TBL] [Abstract][Full Text] [Related]
16. Improving susceptibility of neuroendocrine tumors to radionuclide therapies: personalized approaches towards complementary treatments.
Richter S; Steenblock C; Fischer A; Lemm S; Ziegler CG; Bechmann N; Nölting S; Pietzsch J; Ullrich M
Theranostics; 2024; 14(1):17-32. PubMed ID: 38164150
[TBL] [Abstract][Full Text] [Related]
17. Single-Cell Transcriptome Identifies Drug-Resistance Signature and Immunosuppressive Microenvironment in Metastatic Small Cell Lung Cancer.
Zhang J; Zhang H; Zhang L; Li D; Qi M; Zhang L; Yu H; Wang D; Jiang G; Wang X; Zhu X; Zhang P
Adv Genet (Hoboken); 2022 Jun; 3(2):2100060. PubMed ID: 36618022
[TBL] [Abstract][Full Text] [Related]
18. Single-Cell Transcriptomics Unveils the Dedifferentiation Mechanism of Lung Adenocarcinoma Stem Cells.
Pan Z; Zhang M; Zhang F; Pan H; Li Y; Shao Y; Yuan X; Wang J; Chen J
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613925
[TBL] [Abstract][Full Text] [Related]
19. The cancer stemness inhibitor napabucasin suppresses small cell lung cancer growth through SOX2 expression.
Li JM; Hsu PC; Kuan FC; Shi CS; Yang CT
Am J Cancer Res; 2022; 12(10):4637-4651. PubMed ID: 36381330
[TBL] [Abstract][Full Text] [Related]
20. The Effect and Mechanism of Curcumin Combined with Carboplatin Chemotherapy Promoting on Apoptosis of Lung Cancer HCC827 Cells.
Huang L; He X; Zuo X
J Immunol Res; 2022; 2022():1932692. PubMed ID: 35979255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
